TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharma Systems AB
Closing information (x1000 SEK)
Closing information | 2023/06 (consolidated) | 2021/12 | 2020/12 |
Turnover |
36,342
|
28,277
|
37,000 |
Financial expenses |
216
|
5
|
0 |
Earnings before taxes |
344
|
4,030
|
6,130 |
EBITDA |
2,357
|
4,294
|
6,733 |
Total assets |
22,846
|
32,616
|
40,897 |
Current assets |
15,072
|
28,823
|
28,734 |
Current liabilities |
3,862
|
4,174
|
3,978 |
Equity capital |
14,277
|
24,374
|
35,204 |
- share capital |
206
![]() |
206
![]() |
206 |
Employees (average) |
34
|
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/06 (consolidated) | 2021/12 | 2020/12 |
Solvency |
62.5%
|
74.7%
|
86.1% |
Turnover per employee |
1,069
|
14,138
|
18,500 |
Profit as a percentage of turnover |
0.9%
|
14.3%
|
16.6% |
Return on assets (ROA) |
2.5%
|
12.4%
|
15.0% |
Current ratio |
390.3%
|
690.5%
|
722.3% |
Return on equity (ROE) |
2.4%
|
16.5%
|
17.4% |
Change turnover | |||
Change turnover % |
-24%
|
18% | |
Chg. No. of employees | |||
Chg. No. of employees % |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/06 (consolidated) | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.